Hormone treatment enzalutamide will now be offered as an alternative combined treatment option for some adults with prostate cancer on the NHS in England.
Widely-used anti-inflammatory drugs make tumours in mice more responsive to treatments that harness the power of the body’s own immune system to tackle cancer, according to research funded by Cancer Research UK and published in the journal Cancer Discovery.
The new findings shed light on how cancer cells found in different parts of a tumour behave differently.
Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million through the closing of its initial public offering (IPO).
Around 8 in 10 pancreatic cancer cases are currently diagnosed late in England and Wales.
Using the technology, scientists have revealed that cell division isn’t necessarily the main cause of genetic changes in human tissue DNA.
Scientists are developing a new drug for treating acute myeloid leukaemia (AML), a type of blood cancer that affects around 3,100 people in the UK each year.
Responsible for setting the Charity’s strategic direction, Cancer Research UK’s Council of Trustees plays a vital role in setting the organisation’s agenda.
Cancer Research UK-funded researchers have developed a tool to help experts diagnose a condition that can increase the risk of developing oesophageal cancer.